Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Beatriz Grinsztejn(Fundação Oswaldo Cruz), Myron S. Cohen(University of North Carolina at Chapel Hill), David D. Celentano(Johns Hopkins University), Joseph J. Eron(University of North Carolina at Chapel Hill), Kenneth H. Mayer(Miriam Hospital), Lisa Mills(Kenya Medical Research Institute), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Maija Anderson(Fred Hutch Cancer Center), James Hakim(University of Zimbabwe), Karin Nielsen‐Saines(University of California, Los Angeles), Susan Swindells(University of Nebraska Medical Center), N. Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Marybeth McCauley(Family Health International 360), Joel E. Gallant(Johns Hopkins University), Ravindre Panchia(Chris Hani Baragwanath Hospital), Ian Sanne(University of the Witwatersrand), Taha E. Taha(Blantyre Institute for Community Ophthalmology), Theresa Gamble(University of Utah), Max Essex(Harvard University), Diane V. Havlir(University of California, San Francisco), José Henrique Pilotto(Universidade Iguaçu), Susan H. Eshleman(Johns Hopkins University), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheela Godbole(The Ohio State University Wexner Medical Center), Lei Wang(Capital Medical University), Irving Hoffman(Communities In Schools of Orange County), Joseph Makhema(University of Namur), San-San Ou(Fred Hutch Cancer Center), Heather J. Ribaudo(Cancer Research And Biostatistics), Marineide Gonçalves de Melo(Hospital Nossa Senhora da Conceição), Mina C. Hosseinipour
Cited by 513
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k